Medicines in Development for Cancer 2015 Report

PhRMA September 11, 2015

In recent decades, tremendous – almost previously unthinkable – progress has been made in the fight against cancer. Advances in molecular and genomic research have revealed underlying complexities and provided insights into cancer, which we now know is actually more than 200 unique diseases. Continued research has expanded our knowledge of how the disease develops and how to target medicines for specific cancer types – resulting in more effective therapies for patients. Researchers are exploring new hightech methods to fight the disease as well as new ways to maximize the use of existing medicines, either alone or in combination with other therapies, to treat various forms of the disease. In fact, biopharmaceutical companies are developing 836 medicines and vaccines for cancer, all of which are in clinical trials or awaiting review by the U.S. Food and Drug Administration (FDA).